Nonetheless, we believe that this study has clinical significance as it is the first pilot study to investigate the correlation between initial MPO-ANCA titres and future ESKD progression among MPA patients in the rituximab treatment setting. This evidence concerns the gene MPO and microscopic polyangiitis.